FDA advisers vote against recommending approval of MDMA as treatment for PTSD
(NEW YORK) -- A panel of independent advisers for the U.S. Food and Drug Administration voted against recommending approval of psychedelic treatment -- along with therapy -- to treat post-traumatic stress disorder (PTSD) during a meeting on Tuesday.The treatment, developed by Lykos Therapeutics, is... Read More.